Duration of anticoagulant therapy for venous thromboembolism

被引：3
|
作者：
Raju, Nina C. [1 ]
Hirsh, Jack [1 ]
Eikelboorn, John W. [1 ,2 ]
机构：
[1] McMaster Univ, Dept Med, Hamilton, ON, Canada
[2] McMaster Clin, Thrombosis Serv, Hamilton, ON, Canada
来源：
MEDICAL JOURNAL OF AUSTRALIA | 2009年 / 190卷 / 12期
关键词：
1ST EPISODE; MANAGEMENT; DIAGNOSIS; LONG;
D O I：
10.5694/j.1326-5377.2009.tb02629.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：659 / 660
页数：2
相关论文
共 50 条
  • [41] ANTICOAGULANT THERAPY FOR VENOUS THROMBOEMBOLISM - UNRESOLVED ISSUES AND CURRENT RECOMMENDATIONS
    COON, WW
    POSTGRADUATE MEDICINE, 1978, 63 (04) : 157 - 164
  • [42] The impact of advanced age on anticoagulant therapy for acute venous thromboembolism
    Lafaie, Ludovic
    Celarier, Thomas
    Monreal, Manuel
    Mismetti, Patrick
    Delavenne, Xavier
    Bertoletti, Laurent
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2022, 18 (01) : 27 - 37
  • [43] Anemia and bleeding in patients receiving anticoagulant therapy for venous thromboembolism
    Amir Kuperman
    Raquel López-Reyes
    Lopez-Saez Juan Bosco
    Alicia Lorenzo
    Bascuñana José
    Dominique Farge Bancel
    María Alfonso
    Marina Lumbierres
    Galia Stemer
    Manuel Monreal Bosch
    Andrei Braester
    Journal of Thrombosis and Thrombolysis, 2018, 45 : 360 - 368
  • [44] Anemia and bleeding in patients receiving anticoagulant therapy for venous thromboembolism
    Kuperman, Amir
    Lopez-Reyes, Raquel
    Juan Bosco, Lopez-Saez
    Lorenzo, Alicia
    Jose, Bascunana
    Bancel, Dominique Farge
    Alfonso, Maria
    Lumbierres, Marina
    Stemer, Galia
    Monreal Bosch, Manuel
    Braester, Andrei
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2018, 45 (03) : 360 - 368
  • [45] Mortality Rates Among Patients With Venous Thromboembolism on Anticoagulant Therapy
    Nutescu, Edith
    Song, Xue
    Bookhart, Brahim
    Shi, Nianwen
    Raut, Monika
    Damaraju, C. V.
    Schein, Jeff
    Kaatz, Scott
    CIRCULATION, 2014, 130
  • [46] Duration of anticoagulant treatment and recurrence of venous thromboembolism in patients with and without thrombophilic abnormalities
    Taliani, Maria Rita
    Becattini, Cecilia
    Agnelli, Giancarlo
    Prandoni, Paolo
    Moia, Marco
    Bazzan, Mario
    Salvi, RosaMaria
    Ageno, Walter
    Guazzaloca, Giuliana
    Imberti, Davide
    Silingardi, Mauro
    Poggio, Renzo
    THROMBOSIS AND HAEMOSTASIS, 2009, 101 (03) : 596 - 598
  • [47] DURATION OF WARFARIN ANTICOAGULANT-THERAPY AND THE PROBABILITIES OF RECURRENT THROMBOEMBOLISM AND HEMORRHAGE
    PETITTI, DB
    STROM, BL
    MELMON, KL
    AMERICAN JOURNAL OF MEDICINE, 1986, 81 (02): : 255 - 259
  • [48] Direct oral anticoagulant therapy in adolescent venous thromboembolism: A systematic review
    Alqahtani, Shaikha
    Gibbs, Karen DiValerio
    Montanez, Natalie A.
    Krause, Kate J.
    van Ommen, C. Heleen
    Srivaths, Lakshmi V.
    PEDIATRIC BLOOD & CANCER, 2024, 71 (09)
  • [49] Anticoagulant therapy after venous thromboembolism and 10-year mortality
    Larsen, Torben Bjerregaard
    Lip, Gregory Y. H.
    Gorst-Rasmussen, Anders
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 208 : 72 - 78
  • [50] Recurrent venous thromboembolism under anticoagulant therapy:: A high risk in adenocarcinoma?
    Descourt, Renaud
    Le Gal, Gregoire
    Couturaud, Francis
    Mottier, Dominique
    Bressollette, Luc
    Robinet, Gilles
    Roge, Christophe
    Oger, Emmanuel
    Leroyer, Christophe
    THROMBOSIS AND HAEMOSTASIS, 2006, 95 (05) : 912 - 913
12345